Research Options:

Week of Expected Pricing 11/13/2024
Company Name INVIZYNE TECHNOLOGIES INC
Proposed Ticker IZTC
CUSIP 461874109
Business Description Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. We believe that our biomanufacturing platform, known as SimplePath™, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. Our objective with SimplePath™ is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. We believe that SimplePath™ not only can maximize the value of these resources but also will contribute to the development of novel chemical compounds that should open new markets and business opportunities.
Lead Underwriter MDB Capital Holdings, LLC
Co-Managers N/A
Initial Shares 43,00,000
Revised Initial Shares 1,875,000
Initial Price $8.00-$8.00
Revised Price N/A
Final Price $8.00
Final Ticker IZTC

 

 

   
  © 2024 ICE Data Services. All rights reserved.